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COL4A4 mutation in thin basement membrane disease pre- The recent AUSDIAB Study found that 9.4% of com-
viously described in Alport syndrome. munity-based adults had hematuria (abstract; Chadban
Background. Carriers of autosomal-recessive and X-linked et al, Nephrology 5:107A, 2000), and many of these haveAlport syndrome often have a thinned glomerular basement
dysmorphic or red blood cells (RBCs) of glomerularmembrane (GBM) and have mutations in the COL4A3/COL4A4
origin on phase contrast microscopy. Thin basement mem-and COL4A5 genes respectively. Recently, we have shown
that many individuals with thin basement membrane disease brane disease (TBMD) or “benign familial hematuria”
(TBMD) are also from families where hematuria segregates is the most common diagnosis in renal biopsies from
with the COL4A3/COL4A4 locus. This study describes the individuals with persistent dysmorphic hematuria andfirst COL4A4 mutation in an individual with biopsy-proven
normal renal function [1], and in such individuals, thereTBMD who did not have a family member with autosomal-
is a uniformly thinned glomerular basement membranerecessive or X-linked Alport syndrome, inherited renal failure,
or deafness. (GBM) on ultrastructural examination. As the alterna-
Methods. The index case and all available family members tive name “benign familial hematuria” indicates, TBMD
were examined for dysmorphic hematuria 50,000/mL using is often inherited, and the inheritance pattern is thenphase contrast microscopy and for segregation of hematuria
autosomal dominant [2, 3].with the COL4A3/COL4A4 and COL4A5 loci using DNA satel-
Alport syndrome is another inherited abnormality af-lite markers. COL4A4 exons from the index case were then
studied using the enzyme mismatch cleavage method, and exons fecting the GBM. Clinical features include hematuria,
that demonstrated abnormal cleavage products were sequenced. renal failure, and often deafness and ocular defects, and
Results. Hematuria in this family segregated with a haplo- the GBM is typically lamellated. Inheritance is usuallytype at the COL4A3/COL4A4 locus (P  0.031) but not with
X-linked or autosomal-recessive, when mutations occurhaplotypes at the COL4A5 locus. A mutation in COL4A4 that
in the COL4A5 [4] or COL4A3/COL4A4 [5, 6] geneschanged C to T resulting in an arginine residue being replaced
by a stop codon (R1377X) was demonstrated in exon 44, which respectively.
encodes part of the 4(IV) collagen sequence close to the The demonstration of a thinned GBM in heterozy-
junction with the noncollagenous domain. This mutation was
gotes from families with autosomal-recessive Alport syn-present in all five family members with hematuria, but not in
drome [7, 8] first suggested that TBMD might representthe four unaffected family members, 33 unrelated individuals
with TBMD, or 22 nonhematuric normals. a carrier state for this condition [9, 10] or at least be
Conclusions. R1377X has been described previously in a due to mutations in the same genes. We have recently
compound heterozygous form of autosomal-recessive Alport examined the families of 22 individuals with biopsy-
syndrome. Our observation is evidence that TBMD can repre-
proven TBMD, and found that 8 (36%) had hematuriasent a carrier state for autosomal-recessive Alport syndrome
that segregated with the COL4A3/COL4A4 locus forin at least some individuals.
autosomal-recessive Alport syndrome [11]. Although
carriers of X-linked Alport syndrome often also have
1 See Editorial by Monnens, p. 799 thinned membranes [12], they can usually be identified
by localized regions of GBM lamellation.Key words: collagen type IV, hematuria, glomerular basement mem-
brane, inherited disease, gene mutation. Here we describe a family with TBMD caused by a
mutation in the COL4A4 gene. This is the first time thatReceived for publication September 27, 2000
a mutation has been described in TBMD where thereand in revised form February 27, 2001
Accepted for publication March 5, 2001 was no family member with autosomal-recessive (or
X-linked) Alport syndrome. Furthermore, this mutation 2001 by the International Society of Nephrology
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had been demonstrated previously in a compound het- stop solution [95% formamide, 20 mmol/L ethylenedi-
erozygous form of autosomal-recessive disease [8]. Thus, aminetetraacetic acid (EDTA)] was added to each tube,
this mutation that causes TBMD in the absence of a which was incubated at 95C for 30 minutes and then
family history of autosomal-recessive Alport syndrome chilled. Six microliters from each reaction mix was then
can still represent a carrier state for autosomal-recessive electrophoresed in a 7% denaturing polyacrylamide gel
Alport disease. at 50C for two to four hours. Alleles were determined
by exposing the gel to x-ray film (Biomax; Kodak, Roch-
ester, NY, USA) and assigned numbers according to bandMETHODS
size. Genotypes for the COL4A4 RFLP were determined
Patients after amplification, restriction with HaeIII (Boehringer
The index case was first investigated 18 years pre- Mannheim, Mannheim, Germany) at 37C for four hours
viously when he was 59 years old. At that time, he had and electrophoresis in a 1% agarose gel.
75,000 dysmorphic red blood cells (RBC)/mL on phase Haplotypes were constructed at the COL4A5 and
contrast microscopy of a midstream urine specimen, ap- COL4A3/COL4A4 loci for affected and unaffected fam-
proximately 500 mg proteinuria per day, and a normal ily members. The family was too small for formal linkage
serum creatinine [13]. His 44-year-old daughter and her studies, but the probabilities of hematuria segregating
three children aged 13, 15 and 18 currently all had with haplotypes at each locus were calculated [11].
50,000 dysmorphic RBC/mL in their urine.
The index case’s renal biopsy at presentation con- Mutation detection
tained eight glomeruli, most with mild-to-moderate mes- The enzyme mismatch cleavage method was used to
angial thickening and occasional areas of segmental scle- detect the mutation in the index case [18]. With this
rosis, and with one completely sclerosed glomerulus. method, patient and radiolabeled wild-type DNA form
Only minor patchy interstitial fibrosis and tubular atro- heteroduplexes that are digested by bacterial endonucle-
phy, occasional chronic inflammatory and foam cells, and ases wherever there are mismatches and mutations are
mild vascular changes were found. Mesangial and para- demonstrated by novel banding patterns on autoradiog-
mesangial IgM was present. On electron microscopy, raphy. This technique demonstrates at least 95% of all
there was widespread attenuation of the GBM, which mutations.
averaged 196 nm (112 to 280 nm), some irregular floccu- Patient and wild-type DNA were amplified separately
lar expansion of the lamina rara interna, occasional intra- using specific primers for each exon of COL4A4 [8],
membranous spherical electron dense bodies, and gener-
which for wild-type DNA had been end-labeled with
alized foot process effacement. There was no lamellation
32P-ATP. The amplification products were purified us-of the GBM. The diagnosis of TBMD with secondary
ing “Freeze ’N Squeeze” DNA gel extraction spin col-focal glomerulosclerosis was made [14].
umns (Quantum Prep; Bio-Rad, Hercules, CA, USA).None of the family members who were examined had
Fifty nanograms of each patient and wild-type DNArenal impairment, a clinically detectable hearing loss,
were then heated to 95C for 6.5 minutes, 65C foranterior lenticonus, or retinopathy typical of X-linked
30 minutes, and 25C for 20 minutes to allow hetero-or autosomal-recessive Alport syndrome. Furthermore,
duplex formation. Five microliters of a 10  restrictionthere was no family history of renal failure or inherited
buffer [0.5 mol/L Tris, 100 mmol/L MgCl2, 5 mmol/Ldeafness.
dithiothreitol (DTT), bovine serum albumin (BSA) 1
mg/mL; Boehringer Mannheim] were added, and theLinkage studies
reaction mix was incubated with 250 units of T7 endonu-DNA from peripheral blood leukocytes or buccal smears
clease I in a total volume of 50 L at 37C for 20 towas extracted and amplified using standard techniques
25 minutes, precipitated on ice with 100% ethanol; theand published conditions. Linkage to the COL4A5 locus
precipitate resuspended in 5 L of stop solution (95%was examined using the 2B6 and DXS456 markers [15, 16]
formamide, 20 mmol/L EDTA). This was electropho-and to the COL4A3/COL4A4 locus using the CA11,
resed in a 7% acrylamide gel containing 5.6 mol/L ureaD2S351, and D2S401 markers and a COL4A4 HaeIII intra-
and 32% formamide at 80 watts for approximately onegenic restriction fragment length polymorphism (RFLP)
hour per 100 bp of product. The gel was exposed to x-ray[7, 17]. Each 10L reaction mix contained 50 ng genomic
film at 80C overnight.DNA, 100 ng primers with the 3	 primer end labeled with
Exons containing possible mutations were then ampli-32P-ATP using T4 polynucleotide kinase (Geneworks,
fied (BigDye Terminator Cycle Sequencing Ready reac-Adelaide, South Australia, Australia), 1 mmol/L dNTP
tion), purified, and sequenced in an automated DNA(Pharmacia, Uppsala, Sweden), 1 L of 10  reaction
sequencer. The exon containing the mutation was ampli-buffer, 2.5 mmol/L MgCl2, and 0.5  Taq polymerase
(Geneworks). After amplification, 5 L of formamide fied in the other eight family members, 33 unrelated
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Fig. 1. Family tree showing that hematuria seg-
regated with the COL4A3/COL4A4 locus (P
0.031; A) but not with the COL4A5 locus (B).
Fig. 2. Sequence showing the 4337 C-T muta-
tion in the index case.
individuals with TBMD, and 22 normal individuals who encodes part of the collagen sequence close to the junc-
tion with the noncollagenous domain of the4(IV) mole-did not have hematuria.
This project had the approval of the Human Research cule. There were no mutations in any other COL4A4
exons in the index case from this family.Ethics Committee of the Austin and Repatriation Medi-
cal Centre, and all subjects provided signed informed R1377X was present in all five members of the family
with hematuria but not in the four unaffected familyconsent.
members, 33 unrelated individuals with TBMD, or 22
nonhematuric normals.
RESULTS
In this family, hematuria segregated with the 2121
DISCUSSIONhaplotype at the COL4A3/COL4A4 locus (P  0.031)
and not with the COL4A5 locus (Fig. 1). To our knowledge, this is the first example of a muta-
tion being demonstrated in an individual with biopsy-A C to T substitution at nucleotide 4337 resulting in
an arginine being replaced by a stop codon (R1377X) [9] proven TBMD where there were no family members
known to have autosomal-recessive Alport syndrome andwas demonstrated in exon 44 of COL4A4 (Fig. 2). This
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